As reported across a wide range of media, a jury in California has hit Monsanto and Bayer with a $2 billion-plus damages verdict over serious cancer risks associated with its Roundup weedkiller, the third consecutive trial loss for Bayer and Monsanto relating to aggressive cancer injuries held to stem from use of the Roundup herbicide. After less than two days of deliberations, the 12 member jury determined that it was more likely than not that Roundup was a “significant contributing factor” in the plaintiffs’ non-Hodgkin lymphoma. The plaintiffs’ suit claimed that decades of Roundup use on their properties gave them both aggressive cancer.
There are presently over 13,000 other lawsuits pending against Bayer and Monsanto over Roundup’s active ingredient glyphosate’s cancer-causing properties. Bayer quickly issued a statement that it will be appealing the verdict. This despite the fact that plaintiffs’ expert presented “animal studies, mechanistic data and epidemiological data showing that glyphosate is genotoxic, or DNA damaging, and causes oxidative stress, which can cause cancer mutations. They also cited the International Agency for Research on Cancer’s 2015 finding that glyphosate is a probable carcinogen.”
The expert further explained that “Monsanto made glyphosate 50 times more toxic by selling its Roundup formula with polyethoxylated tallow amine — or POEA — which is a surfactant that is banned in Europe. Surfactants allow glyphosate to easily penetrate the skin.”
If you’d like to talk to an injury lawyer at Lieff Cabraser about your potential Roundup case, call us today at 1 800 541-7358 or use the form on this page.